Teachers Advisors LLC lessened its holdings in Endo International plc (NASDAQ:ENDP) (TSE:ENL) by 67.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 261,782 shares of the company’s stock after selling 550,046 shares during the period. Teachers Advisors LLC’s holdings in Endo International were worth $2,029,000 as of its most recent filing with the SEC.
Several other institutional investors have also made changes to their positions in ENDP. Cornerstone Capital Management Holdings LLC. boosted its position in shares of Endo International by 64.0% in the third quarter. Cornerstone Capital Management Holdings LLC. now owns 135,627 shares of the company’s stock valued at $1,160,000 after acquiring an additional 52,927 shares during the period. Nisa Investment Advisors LLC bought a new stake in shares of Endo International in the fourth quarter valued at about $236,000. Oakbrook Investments LLC bought a new stake in shares of Endo International in the fourth quarter valued at about $133,000. Alps Advisors Inc. boosted its position in shares of Endo International by 22.9% in the fourth quarter. Alps Advisors Inc. now owns 307,839 shares of the company’s stock valued at $2,386,000 after acquiring an additional 57,328 shares during the period. Finally, River & Mercantile Asset Management LLP boosted its position in shares of Endo International by 32.7% in the fourth quarter. River & Mercantile Asset Management LLP now owns 475,650 shares of the company’s stock valued at $3,679,000 after acquiring an additional 117,110 shares during the period. 94.77% of the stock is owned by institutional investors.
ENDP stock opened at $5.46 on Tuesday. The stock has a market capitalization of $1,223.90, a P/E ratio of 1.43 and a beta of 0.38. Endo International plc has a 52 week low of $5.27 and a 52 week high of $14.15. The company has a debt-to-equity ratio of 17.00, a current ratio of 1.02 and a quick ratio of 0.85.
Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.77 EPS for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.15. The business had revenue of $768.64 million during the quarter, compared to the consensus estimate of $762.29 million. Endo International had a positive return on equity of 81.03% and a negative net margin of 58.68%. Endo International’s revenue for the quarter was down 38.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.77 earnings per share. sell-side analysts predict that Endo International plc will post 2.33 earnings per share for the current fiscal year.
A number of brokerages have recently issued reports on ENDP. BidaskClub cut shares of Endo International from a “sell” rating to a “strong sell” rating in a research report on Friday, April 6th. Canaccord Genuity set a $7.00 target price on shares of Endo International and gave the company a “hold” rating in a research report on Wednesday, February 21st. Oppenheimer reissued a “hold” rating on shares of Endo International in a research report on Tuesday, February 27th. Barclays set a $9.00 target price on shares of Endo International and gave the company a “hold” rating in a research report on Saturday, March 10th. Finally, Mizuho cut shares of Endo International from a “buy” rating to a “neutral” rating and reduced their target price for the company from $12.00 to $7.00 in a research report on Wednesday, April 4th. Four investment analysts have rated the stock with a sell rating, sixteen have assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $9.40.
WARNING: This report was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/17/teachers-advisors-llc-sells-550046-shares-of-endo-international-plc-endp.html.
Endo International Profile
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
Want to see what other hedge funds are holding ENDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Endo International plc (NASDAQ:ENDP) (TSE:ENL).
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.